Clinical Trial Update: A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating neoadjuvant androgen ablation with cyclophosphamide and GVAX vaccine in localized prostate cancer (Phase 1 and Phase 2; completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• GVAX vaccine
• androgen ablation

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer Adenocarcinoma in Situ | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-11-01